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Intraflagellar transport (IFT) is required for proper function of cilia, although many of the mechanistic details
underlying this process are obscure. Two studies in this issue of Developmental Cell illuminate key functions
of one IFT protein, IFT27, and offer clues into how IFT cargo is selected and transported.Intraflagellar transport (IFT), the regulated
movement of cargo along the ciliary
axoneme, is critical for ciliary biogenesis
and function (Pedersen and Rosenbaum,
2008). Complete disruption of IFT leads
to either failure of ciliogenesis or severe
distortion of ciliary architecture, both of
which are incompatible with life, while
hypomorphic mutations give rise to
severe multi-organ pathologies that, in
humans, manifest in acute neonatal disor-
ders (Davis and Katsanis, 2012). In this
issue of Developmental Cell, Eguether
et al. (2014) and Liew et al. (2014) provide
molecular insights into the mechanisms
underlying IFT cargo selection and hint
at regulated interactions between some
IFT components and other ciliary com-
plexes to regulate paracrine signaling
(Eguether et al., 2014; Liew et al., 2014).
Initial biochemical studies of IFT defined
twokeyparticles, IFT-Band IFT-A. IFT-B is
composed of 16 core members mounted
on kinesin motors and is responsible for
cargo transport from the base of the cilium
to the tip (anterograde transport). IFT-A,
the retrograde core particle, is composed
of six core proteins driven by dynein
motors (Pedersen and Rosenbaum,
2008). Some, but not all, IFT proteins also
participate in non-ciliary transport, in a
cell-type-specific manner (Garcia-Gon-
zalo et al., 2011). The two reports in this
issue of Developmental Cell reveal further
complexity and suggest that IFT27, histor-
ically considered a dedicated anterograde
transport protein, may also participate in
retrograde transport (Eguether et al.,
2014; Huet et al., 2014; Liew et al., 2014).
These findings additionally highlight a link
between IFT and the BBSome, a complex
of proteins that, when mutated, cause
Bardet-Biedl syndrome (BBS; Nachury
et al., 2007). While the BBSome is criticalfor the sorting of membrane proteins,
including components of the sonic hedge-
hog (SHH) signaling pathway, into the
cilium (Seo et al., 2011), the mechanisms
facilitating the selective transport of such
proteins out of the cilium are unclear.
Eguether and colleagues (2014) investi-
gated the molecular underpinnings of the
ciliopathy phenotypes observed in a new
Ift27/ mouse model, including polydac-
tyly, cardiac malformations, situs inversus,
and craniofacial defects. The authors
noted that although Ift27/mouseembry-
onicfibroblasts (MEFs)donotdisplayovert
structural defects indicative of disrupted
IFT, they exhibit attenuated SHH signaling
concomitantwith theaccumulationofSHH
components, including the transmem-
brane receptors patched (PTCH), smooth-
ened (SMO), and the SHH G protein-
coupled receptor intermediate GPR161.
Moreover, in the absence of IFT27, the
authors observed aberrant ciliary localiza-
tion of multiple BBSome components, as
well as BBSome-associated proteins
such as ARL6/BBS3 and LZTFL1/BBS17.
The authors also found that cells lacking
Lztfl1, another causative BBS gene that
participates in BBSome-mediated protein
trafficking (Seo et al., 2011), accumulate
BBSome proteins but not IFT27. As such,
they propose that LZTFL1 cooperates
with IFT27 to facilitate retrograde transport
of BBS and SHH proteins.
In a parallel study, Liew et al. (2014) uti-
lized ciliated in vitro models coupled with
biochemical analyses to examine the
interaction of IFT27 with the BBSome.
First, the authors found that IFT27 binds
to ARL6. ARL6 is a GTPase, like IFT27,
and a known effector of the BBSome,
required for its targeting to the cilium. In
addition, cells with both suppressed Ift27
expression and Ift27/MEFSwere foundDevelopmental Cell 31, Nto accumulate BBSome components and
ARL6 in their cilia. Finally, and consistent
with a previously suggested role for the
BBSome in sorting SHH signaling compo-
nents entering the cilium upon pathway
activation (Seo et al., 2011), lack of IFT27
resulted in the ciliary accumulation of
transmembrane receptors PTCH, SMO,
and GPR161, presumably because these
proteins fail to exit. The authors propose
that, in addition toacanonical role in anter-
ograde transport in cooperation with the
IFT-B complex, IFT27 can dissociate
from IFT-B to bind and activate ARL6, a
process necessary for targeted removal
of SHH components from the cilium.
Together, these two studies hint at a
previously underappreciated interaction
between two of themost highly character-
ized ciliary modules, the IFT machinery,
and the BBSome, and provide important
new clues about trafficking of signaling
moieties from the ciliary compartment to
the cell (Figure 1). However, the biological
reality is likely to be even more complex.
For instance, suppression of ift27 in Chla-
mydomonas or Trypanosoma caused a
reduction of IFT-A and IFT-B amounts
(Huet et al., 2014; Qin et al., 2007) and
concomitant shortening of the axoneme,
arguing for a role of IFT27 in IFT particle
stability. This was not observed in the
models used by Eguether et al. (2014)
and Liew et al. (2014), suggesting that
either this IFT27 function has been lost in
higher vertebrates or that it might only
exist in cell types not interrogated in the
current studies. In addition, the defects
in SHH component trafficking raises the
question of whether IFT27 is dedicated
to responding to SHH activation or
whether this method of removing proteins
from the cilium might also apply to
other signaling molecules. All of theseovember 10, 2014 ª2014 Elsevier Inc. 263
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Figure 1. Ciliary Effects of Ift27 Depletion
(A and B) SHH signaling in wild-type (WT) cells. (A) Transmembrane receptor patched (PTCH) represses smoothened (SMO) in the absence of ligand, and Gli
repressor maintains suppression of SHH targets in the nucleus. (B) SHH ligand binds to PTCH, SMO is derepressed by bound PTCH, Gli localizes to the cilium,
and then signal is transduced to the nucleus to induce target gene transcription. SHH intermediate G protein-coupled receptor 161 (GPR161) is trafficked nor-
mally in the cilium. BBS-related proteins remain at the basal body. IFT-B (green rectangle) and IFT-A (blue rectangle) conduct anterograde and retrograde move-
ment of cargo, respectively. (C and D) SHH signaling in Ift27/ cells. (C) BBS-associated proteins mislocalize to the cilium, SMO and PTCH are retained, and an
excess of GPR161 is localized to the cilium, likely due to a failure of retrograde transport facilitated by IFT27. (D) In the presence of ligand, Gli fails to activate, likely
due to mislocalization of signaling proteins in the cilium.
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Previewsquestions must be placed in the broader
context of ciliary function in different tis-
sues and developmental time points.
Finally, it will be important to place
these findings in the context of human ge-
netic disease. Ift27/mice exhibit severe
ciliopathy hallmarks and cannot survive
past birth (Eguether et al., 2014), while
patients with apparent loss-of-function
alleles in the same molecule have BBS,
an intermediate ciliopathy (Aldahmesh
et al., 2014). These discordant observa-
tions may be driven by allelic differences
or by non-identical functions of IFT27 in
mice and humans. Ultimately, the synthe-
sis of data from diverse cell types,
organisms, and developmental and ho-
meostatic contexts will be required to264 Developmental Cell 31, November 10, 20gain a deeper appreciation of the diverse
roles of IFT proteins, their accessory sub-
units, their cargo, and, more broadly, the
complexity that underpins ciliary function.
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